#ASCO22, Twitter, 6/11/2022 4:39:45 AM, 278098


FAQ | Problem?

#ASCO22_2022-06-10_19-41-38.xlsx
#ASCO22_2022-06-10_19-41-38.xlsx
From:
Connected Action NodeXL-Reports
Uploaded on:
June 11, 2022
Short Description:
#ASCO22 via NodeXL https://bit.ly/3QcQojR
@asco
@oncoalert
@nuenojpn
@acmoorephd
@nodexl_mktng
@nejm
@marklewismd
@tmprowell
@mskcancercenter
@erictopol

Top hashtags:
#asco22
#lcsm
#bcsm
#breastcancer
#cancer
#oncology
#rectalcancer
#crcsm
#covid19
#nsclc

Description:
Description
The graph represents a network of 8,717 Twitter users whose recent tweets contained "#ASCO22", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Saturday, 11 June 2022 at 03:19 UTC.

The tweets in the network were tweeted over the 4-day, 9-hour, 0-minute period from Monday, 06 June 2022 at 17:29 UTC to Saturday, 11 June 2022 at 02:29 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 8717
Unique Edges : 31576
Edges With Duplicates : 20118
Total Edges : 51694
Number of Edge Types : 5
Retweet : 13604
MentionsInRetweet : 25057
Mentions : 9901
Tweet : 2343
Replies to : 789
Self-Loops : 2458
Reciprocated Vertex Pair Ratio : 0.0632959680732437
Reciprocated Edge Ratio : 0.119056161170139
Connected Components : 334
Single-Vertex Connected Components : 208
Maximum Vertices in a Connected Component : 8102
Maximum Edges in a Connected Component : 50671
Maximum Geodesic Distance (Diameter) : 12
Average Geodesic Distance : 3.668915
Graph Density : 0.000476918311941613
Modularity : 0.391108
NodeXL Version : 1.0.1.449
Data Import : The graph represents a network of 8,717 Twitter users whose recent tweets contained "#ASCO22", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Saturday, 11 June 2022 at 03:19 UTC.

The tweets in the network were tweeted over the 4-day, 9-hour, 0-minute period from Monday, 06 June 2022 at 17:29 UTC to Saturday, 11 June 2022 at 02:29 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

Layout Algorithm : The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.
Graph Source : TwitterSearch
Graph Term : #ASCO22
Groups : The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.
Edge Color : Edge Weight
Edge Width : Edge Weight
Edge Alpha : Edge Weight
Vertex Radius : Betweenness Centrality

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[305] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[138] https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html
[136] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home&cookieSet=1
[50] https://the-comforter.org/
[47] http://onconexion2022.com
[33] https://myriad.com/oncology/precise/
[26] https://bit.ly/3mlp3Ou
[23] https://meetings.asco.org/2022-asco-annual-meeting/14350?presentation=207038#207038
[22] https://www.mskcc.org/news-releases/asco-2022-100-complete-response-rate-mmrd-locally-advanced-rectal-cancer-seen-pivotal-immunoablative-neoadjuvant-immunotherapy-clinical-trial
[21] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445

Top URLs in Tweet in G1:
[42] http://onconexion2022.com
[11] https://www.aacr.org/professionals/research/aacr-project-genie/the-aacr-project-genie-biopharma-collaborative-bpc/bpc-nsclc-2-0-public/
[7] https://twitter.com/drmarkham/status/1533793130956349444
[6] https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.2653?cookieSet=1
[6] https://r.socialstudio.radian6.com/6251cba1-dd7b-4f35-9682-562e0d972013
[6] https://twitter.com/StephenVLiu/status/1533944435632898050
[5] https://conferences.asco.org/am/publications-lounge
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[5] https://fs3.formsite.com/XC07MF/qasfchn9rk/index.html
[5] https://ascopubs.org/doi/10.1200/JCO.22.01003?cookieSet=1

Top URLs in Tweet in G2:
[12] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[9] https://www.statnews.com/2022/06/06/black-cancer-patients-not-offered-access-to-clinical-trials/
[6] https://meetings.asco.org/abstracts-presentations/206798
[6] https://twitter.com/TotalHealthConf/status/1534226936926507015
[6] https://twitter.com/DrSGraff/status/1534188096140546051
[6] https://agendia.com/2022-annual-oncology-conference/
[5] https://accounts.haymarketmedia.com/authcheck?gn=101&retUrl=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-clinical-oncology-asco%2Fasco-2022%2Fcovid-19-gynecologic-cancer-patient-outcomes%2F&NoCheck=true
[5] https://twitter.com/WomenOncologist/status/1533981039118503936
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home&cookieSet=1
[5] https://blog.komen.org/blog/practice-changing-research-results-announced-at-asco/

Top URLs in Tweet in G3:
[11] https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00106-5/fulltext
[10] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137689-asco-2022-a-phase-iii-double-blinded-study-of-early-intervention-after-radical-prostatectomy-with-adt-with-darolutamide-versus-placebo-in-men-at-highest-risk-of-prostate-cancer-metastasis-b?mtm_campaign=Morgans_SocialASCO22_ID137689
[9] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137742-asco-2022-abstract-5040-safety-and-survival-outcomes-in-patients-pts-with-metastatic-castration-resistant-prostate-cancer-mcrpc-treated-with-lutetium-177-prostate-specific-membrane-antigen-?mtm_campaign=Rahbar_SocialASCO22_ID137742
[8] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137714-asco-2022-predictive-value-of-extra-prostatic-disease-detection-by-pre-operative-psma-pet-for-biochemical-recurrence-free-survival-in-patients-treated-with-radical-prostatectomy-follow-up-a?mtm_campaign=Djaileb_SocialASCO22_ID137714
[8] https://ecancer.org/en/video/10418-asco-2022-highlights-and-analysis
[8] https://www.eventbrite.co.uk/e/black-in-cancer-conference-empowering-the-next-generation-tickets-349636260467
[7] https://meetings.asco.org/2022-asco-annual-meeting/14284?presentation=209146#209146
[7] https://meetings.asco.org/abstracts-presentations/207687
[6] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137763-asco-2022-defining-more-precisely-the-effects-of-docetaxel-plus-adt-for-men-with-mhspc-meta-analysis-of-individual-participant-data-from-randomized-trials.html?mtm_campaign=Vale_SocialASCO22_ID137763
[6] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137708-asco-2022-tolerability-of-abiraterone-combined-with-olaparib-in-patients-with-mcrpc-further-results-from-the-phase-iii-propel-trial.html?mtm_campaign=Thiery-Vuillemin_SocialASCO22_ID137708

Top URLs in Tweet in G4:
[274] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[22] https://www.mskcc.org/news-releases/asco-2022-100-complete-response-rate-mmrd-locally-advanced-rectal-cancer-seen-pivotal-immunoablative-neoadjuvant-immunotherapy-clinical-trial
[19] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445
[10] https://www.mskcc.org/news/rectal-cancer-disappears-after-experimental-use-immunotherapy
[10] https://www.parcdesalutmar.cat/ca/noticies/view.php?ID=12151
[9] https://www.statnews.com/2022/06/06/black-cancer-patients-not-offered-access-to-clinical-trials?utm_content=buffer380fe&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic
[6] https://pubmed.ncbi.nlm.nih.gov/35660797/
[6] https://www.nejm.org/doi/full/10.1056/NEJMoa2203690
[6] https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html
[5] https://letswinpc.org/promising-science/2022/06/06/surprising-clinical-trial-results-in-pancreatic-and-rectal-cancer/

Top URLs in Tweet in G5:
[22] https://meetings.asco.org/2022-asco-annual-meeting/14350?presentation=207038#207038
[22] https://bit.ly/3mlp3Ou
[15] https://www.nytimes.com/2022/06/07/health/enhertu-breast-cancer-chemotherapy.html?smid=tw-share
[8] https://meetings.asco.org/abstracts-presentations/search?q=*
[6] https://ascopubs.org/doi/full/10.1200/EDBK_351123?cookieSet=1
[6] https://www.mdanderson.org/newsroom/studies-reveal-new-insights-into-gut-microbiome-impact-on-immunotherapy-response-in-multiple-cancers-including-glioblastoma.h00-159540534.html
[6] https://www.forbes.com/sites/victoriaforster/2022/06/01/risk-of-skin-cancer-depends-on-genetics-as-well-as-sun-exposure-says-new-study/?sh=4c75bd263b80
[6] https://idp.nature.com/authorize?response_type=cookie&client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-022-01726-1
[5] https://www.asco.org/about-asco/press-center/news-releases/use-telemedicine-cancer-care-increased-varied-race
[5] https://meetings.asco.org/2022-asco-annual-meeting/14399?presentation=206894#206894

Top URLs in Tweet in G6:
[5] https://meetings.asco.org/abstracts-presentations/208019
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa2203690?query=featured_home&cookieSet=1
[4] https://meetings.asco.org/abstracts-presentations/210320
[4] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[3] https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202206/575420.html
[2] https://ascopubs.org/doi/full/10.1200/JCO.22.00908?cookieSet=1
[2] https://togetter.com/li/1896226
[2] https://twitter.com/drcmassard/status/1534205767913455619
[2] https://twitter.com/OncBrothers/status/1533947802493063170
[1] https://oncoinfo.it/congressi/studio-rome-la-medicina-di-precisione-italiana-ad-asco-2022/

Top URLs in Tweet in G7:
[6] https://www.saluteh24.com/il_weblog_di_antonio/2022/06/tumore-del-retto-tasso-di-risposta-completa-al-100-senza-chirurgia-radio-e-chemio-asco22.html
[3] https://twitter.com/i/status/1533420142872371200
[2] https://endpts.com/asco22-enhertu-blows-chemotherapy-out-of-the-water-redefining-breast-cancer-subgroups-along-the-way/
[2] http://www.salutedomani.com/article/tumore_del_retto_tasso_di_risposta_completa_al_100_senza_chirurgia_radio_e_chemio_asco22_33745
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[1] https://twitter.com/PortageBiotech/status/1533841204399554563
[1] https://www.linkedin.com/feed/update/urn:li:share:6939635454967259136
[1] https://twitter.com/Adaptimmune/status/1533419583310381057
[1] https://meetings.asco.org/abstracts-presentations/210346
[1] https://firstwordpharma.com/story/5588341

Top URLs in Tweet in G8:
[7] https://twitter.com/tmprowell/status/1534659149778272262
[6] https://twitter.com/drsgraff/status/1534148210037559297
[5] https://www.medscape.com/viewarticle/975219?src=soc_tw_220608_mscpedt_news_mdscp_acetaminophen&faf=1
[4] https://twitter.com/matteolambe/status/1533187028829061121
[2] https://twitter.com/eldsalt/status/1534570037033328640
[2] https://www.sciencedirect.com/science/article/abs/pii/S0167814022000366
[2] https://www.medscape.com/viewarticle/975165?src=soc_tw_220608_mscpedt_news_mdscp_breastcancer&faf=1
[1] https://twitter.com/marklewismd/status/1533526646187335680
[1] https://twitter.com/sarahkarlin/status/1534660182436892673
[1] https://www.medscape.com/viewarticle/975062

Top URLs in Tweet in G9:
[123] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home&cookieSet=1
[123] https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html
[6] https://twitter.com/hashtag/asco22?src=hashtag_click&f=image
[5] https://twitter.com/JackWestMD/status/1533420481554022400?s=20&t=-5OncAVc1j5R_vySaKOuHQ
[4] https://www.fiercebiotech.com/biotech/asco-back-person-first-time-years-not-without-its-challenges
[3] https://www.fiercebiotech.com/biotech/asco-medidata-links-car-ts-cytokine-release-syndrome-risk-common-biomarkers-new-study?utm_source=twitter&utm_medium=sm&utm_content=ascofiercebiotech&utm_campaign=gl-q222-asco22
[3] https://www.nejm.org/doi/full/10.1056/NEJMoa2200075?query=featured_home&cookieSet=1
[3] https://www.nejm.org/doi/full/10.1056/NEJMe2204625?query=recirc_curatedRelated_article&cookieSet=1
[3] https://investors.boltbio.com/static-files/e7d61d1e-a1c5-47b3-9ef4-fe3e78f73131
[2] https://finance.yahoo.com/news/in8bio-announces-positive-glioblastoma-multiforme-110000305.html

Top URLs in Tweet in G10:
[6] https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fda-workshop-7th-annual-clinical-outcome-assessment-cancer-clinical-trials-workshop-06292022
[6] https://www.surveymonkey.com/r/COACCT22
[6] https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/CARVYKTI-pi.pdf
[4] https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.1503?cookieSet=1
[4] https://www.biocentury.com/article/643940/pazdur-rings-bell-for-dose-optimization-wants-to-modernize-clinical-tox
[4] https://twitter.com/Novocure/status/1533793903526150145
[3] https://ir.mirati.com/press-releases/press-release-details/2022/New-Late-Breaking-Data-on-Investigational-Adagrasib-Show-Regression-of-Central-Nervous-System-CNS-Metastases-in-Patients-with-KRASG12C-mutated-Non-Small-Cell-Lung-Cancer-NSCLC-with-Active-Untreated-CNS-Metastases/default.aspx?utm_source=twitter&utm_medium=organic&utm_campaign=asco_organic&utm_content=lba_static
[3] https://meetings.asco.org/abstracts-presentations/211284
[2] https://ir.mirati.com/press-releases/press-release-details/2022/Investigational-Adagrasib-Delivers-Positive-Results-in-Registration-Enabling-Study-of-Patients-with-KRASG12C-Mutated-Advanced-Non-Small-Cell-Lung-Cancer/default.aspx?utm_source=twitter&utm_medium=organic&utm_campaign=asco_organic&utm_content=cohorta_static
[2] https://www.krasregeneration.com/prolific-problem?utm_source=twitter&utm_medium=cpc&utm_campaign=june_hcp_videoviews&utm_id=677047&utm_content=factsheetanimation%26source

Top Domains
Top Domains in Tweet in Entire Graph:
[2189] twitter.com
[674] nejm.org
[546] asco.org
[366] ascopubs.org
[248] myriad.com
[241] urotoday.com
[184] nytimes.com
[119] onclive.com
[115] ascopost.com
[111] com.br

Top Domains in Tweet in G1:
[853] twitter.com
[120] asco.org
[116] ascopubs.org
[76] onclive.com
[68] nejm.org
[65] ascopost.com
[56] onconexion2022.com
[35] medicinematters.com
[27] aacrjournals.org
[23] urotoday.com

Top Domains in Tweet in G2:
[608] twitter.com
[106] ascopubs.org
[92] asco.org
[86] healio.com
[58] nejm.org
[44] cancernetwork.com
[25] blogspot.com
[25] medpagetoday.com
[21] statnews.com
[20] mdedge.com

Top Domains in Tweet in G3:
[251] twitter.com
[207] urotoday.com
[138] asco.org
[76] ascopubs.org
[57] targetedonc.com
[42] wiley.com
[40] cgtlive.com
[39] oncologytube.com
[28] ascopost.com
[20] nejm.org

Top Domains in Tweet in G4:
[362] nejm.org
[54] evaluate.com
[44] mskcc.org
[37] twitter.com
[20] statnews.com
[16] astrazeneca.com
[16] cancer.net
[14] vhio.net
[14] parcdesalutmar.cat
[12] gacetamedica.com

Top Domains in Tweet in G5:
[101] twitter.com
[73] asco.org
[61] nature.com
[39] bit.ly
[30] mdanderson.org
[21] medscape.com
[20] nytimes.com
[16] ascopubs.org
[14] oncnursingnews.com
[11] forbes.com

Top Domains in Tweet in G6:
[10] nejm.org
[9] asco.org
[7] twitter.com
[4] co.jp
[2] ascopubs.org
[2] togetter.com
[1] oncoinfo.it
[1] instagram.com

Top Domains in Tweet in G7:
[39] twitter.com
[34] com.br
[7] saluteh24.com
[6] endpts.com
[5] ascopubs.org
[5] pharmastar.it
[4] linkedin.com
[4] dy.si
[4] nejm.org
[4] caringambassadors.org

Top Domains in Tweet in G8:
[52] twitter.com
[17] medscape.com
[5] sciencedirect.com
[3] blogspot.com
[1] amazonaws.com
[1] thelancet.com
[1] nature.com
[1] onkowissen.tv
[1] linkedin.com
[1] statnews.com

Top Domains in Tweet in G9:
[135] nejm.org
[127] nytimes.com
[17] endpts.com
[14] twitter.com
[9] fiercebiotech.com
[4] medidata.com
[3] asco.org
[3] boltbio.com
[2] yahoo.com
[2] statnews.com

Top Domains in Tweet in G10:
[20] asco.org
[20] biocentury.com
[9] twitter.com
[8] krasregeneration.com
[7] janssenlabels.com
[7] fda.gov
[7] surveymonkey.com
[5] mirati.com
[5] pharm2market.app
[5] fiercebiotech.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[19871] asco22
[1371] lcsm
[1235] bcsm
[739] breastcancer
[607] cancer
[548] oncology
[484] rectalcancer
[450] crcsm
[427] covid19
[321] nsclc



Top Hashtags in Tweet in G1:
[6553] asco22
[1161] lcsm
[309] bcsm
[196] covid19
[192] nsclc
[189] breastcancer
[165] lungcancer
[150] oncology
[144] cancer
[136] gerionc

Top Hashtags in Tweet in G2:
[4651] asco22
[698] bcsm
[317] crcsm
[301] breastcancer
[191] gyncsm
[115] cancer
[113] clinicaltrials
[111] colorectalcancer
[85] oncoalerttoptweet
[84] lcsm

Top Hashtags in Tweet in G3:
[2392] asco22
[181] leusm
[158] mmsm
[156] prostatecancer
[112] mpnsm
[73] lymsm
[67] bcsm
[52] mcrpc
[42] oncotwitter
[40] cancer

Top Hashtags in Tweet in G4:
[1035] asco22
[344] rectalcancer
[64] immunotherapy
[43] asco22vr
[33] cancer
[27] breastcancer
[20] oncology
[18] cancerresearch
[15] crcsm
[15] pancreaticcancer

Top Hashtags in Tweet in G5:
[1123] asco22
[118] endcancer
[50] clecliniccancer
[46] sarcoma
[44] oncology
[40] melanoma
[36] cancer
[35] immunotherapy
[33] glioblastoma
[32] breastcancer

Top Hashtags in Tweet in G6:
[468] asco22
[24] breastcancer
[15] bcareporter
[14] ctdna
[9] ctcs
[9] liquidbiopsy
[8] bcsm
[7] precisionmedicine
[7] metastatic
[7] mbc

Top Hashtags in Tweet in G7:
[298] asco22
[20] oncology
[19] mdhealth
[19] oncologiabrasil
[12] cancer
[10] lungcancer
[8] asco
[7] bcsm
[6] breastcancer
[6] câncerdepróstata

Top Hashtags in Tweet in G8:
[291] asco22
[141] covid19
[89] onctwitter
[33] asco2022
[25] immunocompromised
[20] lcsm
[12] aua22
[5] breastcancer
[4] bcsm
[4] gyncsm

Top Hashtags in Tweet in G9:
[236] asco22
[29] ddw2022
[6] covid19
[5] cartcelltherapy
[4] clinicalresearch
[3] lcsm
[3] cytokinereleasesyndrome
[3] patients
[3] ai
[3] lesaviezvouscovid

Top Hashtags in Tweet in G10:
[235] asco22
[24] kpatasco
[22] cancer
[19] nsclc
[19] lungcancer
[18] lcsm
[16] bcsm
[13] tumortreatingfieldstherapy
[12] clinicaltrials
[11] breastcancer

Top Words
Top Words in Tweet in Entire Graph:
[19880] #asco22
[4905] asco
[4279] cancer
[4015] patients
[2639] oncoalert
[2386] dr
[2007] study
[1935] trial
[1748] more
[1576] clinical

Top Words in Tweet in G1:
[6537] #asco22
[2011] asco
[1203] oncoalert
[1161] #lcsm
[1136] cancer
[970] patients
[919] dr
[677] great
[517] data
[505] trial

Top Words in Tweet in G2:
[4656] #asco22
[1270] asco
[1235] oncoalert
[1178] patients
[1153] cancer
[698] #bcsm
[577] dr
[486] breast
[483] more
[466] presented

Top Words in Tweet in G3:
[2410] #asco22
[561] asco
[505] patients
[474] cancer
[393] study
[373] trial
[300] dr
[270] phase
[265] presented
[258] gt

Top Words in Tweet in G4:
[1041] #asco22
[492] nejm
[426] asco
[399] advanced
[388] published
[380] locally
[380] mskcancercenter
[376] clinical
[365] response
[358] deficient

Top Words in Tweet in G5:
[1126] #asco22
[254] cancer
[238] patients
[200] dr
[193] asco
[165] trial
[147] more
[138] study
[118] #endcancer
[117] session

Top Words in Tweet in G6:
[468] #asco22
[359] 04
[354] がんの治療開発でホームランを打つことは滅多にない
[354] 今回チームで取り組んだdestiny
[354] 臨床試験は
[354] ホームランだった
[354] 満場総立ちの拍手喝采
[354] を始めて研究者として
[354] シカゴで経験した
[354] ホルモン陽性転移性乳がんに新しい治療が到来する

Top Words in Tweet in G7:
[298] #asco22
[59] cancer
[45] em
[36] patients
[28] trial
[28] data
[27] estudo
[26] more
[24] great
[22] asco

Top Words in Tweet in G8:
[295] #asco22
[262] news
[164] ton
[141] #covid19
[121] please
[114] attended
[108] pos
[101] good
[101] tests
[97] rapid

Top Words in Tweet in G9:
[254] complete
[254] remission
[236] #asco22
[147] patients
[142] cancer
[130] 18
[128] repair
[127] single
[127] patient
[127] unheard

Top Words in Tweet in G10:
[236] #asco22
[59] more
[59] cancer
[47] patients
[37] clinical
[36] re
[36] dr
[35] research
[35] data
[31] trial

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[1415] asco,#asco22
[818] breast,cancer
[770] #asco22,oncoalert
[667] lung,cancer
[556] mismatch,repair
[553] repair,deficient
[506] locally,advanced
[488] #asco22,#lcsm
[472] presented,#asco22
[443] #asco22,asco

Top Word Pairs in Tweet in G1:
[635] asco,#asco22
[416] #asco22,#lcsm
[416] lung,cancer
[339] #asco22,oncoalert
[198] #asco22,dr
[177] attend,#asco22
[177] #asco22,asco
[167] #asco22,person
[165] community,important
[164] trained,virologist

Top Word Pairs in Tweet in G2:
[383] #asco22,oncoalert
[377] breast,cancer
[257] asco,#asco22
[225] #asco22,#bcsm
[204] her2,low
[152] clinical,trials
[145] practice,changing
[143] #asco22,asco
[133] #bcsm,#asco22
[131] presented,#asco22

Top Word Pairs in Tweet in G3:
[170] gt,asco
[167] #asco22,written
[167] written,coverage
[97] asco,pcfnews
[86] coverage,zklaassen_md
[84] coverage,walliscjd
[82] walliscjd,uoft
[80] #asco22,#mpnsm
[79] uoft,gt
[79] #asco22,#leusm

Top Word Pairs in Tweet in G4:
[378] locally,advanced
[356] deficient,locally
[352] mismatch,repair
[352] repair,deficient
[345] published,nejm
[335] asco,#asco22
[330] complete,response
[321] advanced,#rectalcancer
[311] 100,clinical
[311] dostarlimab,alone

Top Word Pairs in Tweet in G5:
[57] breast,cancer
[46] #asco22,#endcancer
[39] asco,#asco22
[37] immune,checkpoint
[35] clinical,trial
[34] lung,cancer
[34] checkpoint,blockade
[33] more,#asco22
[32] dana,farber's
[30] poster,discussion

Top Word Pairs in Tweet in G6:
[354] がんの治療開発でホームランを打つことは滅多にない,今回チームで取り組んだdestiny
[354] 今回チームで取り組んだdestiny,04
[354] 04,臨床試験は
[354] 臨床試験は,ホームランだった
[354] ホームランだった,満場総立ちの拍手喝采
[354] 満場総立ちの拍手喝采,を始めて研究者として
[354] を始めて研究者として,#asco22
[354] #asco22,シカゴで経験した
[354] シカゴで経験した,ホルモン陽性転移性乳がんに新しい治療が到来する
[354] ホルモン陽性転移性乳がんに新しい治療が到来する,成功の余韻を楽しんでいる

Top Word Pairs in Tweet in G7:
[18] em,#mdhealth
[18] #mdhealth,#oncologiabrasil
[16] completo,em
[14] breast,cancer
[14] conteúdo,completo
[13] her2,low
[11] presented,#asco22
[10] learn,more
[10] saiba,mais
[10] mais,em

Top Word Pairs in Tweet in G8:
[164] news,ton
[95] attended,#asco22
[94] #covid19,rapid
[94] rapid,tests
[94] good,news
[83] bad,news
[82] ton,attended
[82] #asco22,taking
[82] taking,#covid19
[82] tests,bad

Top Word Pairs in Tweet in G9:
[254] complete,remission
[128] cancer,#asco22
[127] remission,single
[127] single,patient
[127] patient,unheard
[127] unheard,'
[127] ',combining
[127] combining,genomics
[127] genomics,diagnosis
[127] diagnosis,mismatch

Top Word Pairs in Tweet in G10:
[27] learn,more
[16] view,presentation
[16] presentation,details
[16] small,cell
[15] non,small
[12] clinical,trials
[11] lung,cancer
[11] #asco22,re
[11] cell,#lungcancer
[11] #asco22,#lcsm

Top Replied-To
Top Replied-To in Entire Graph:
@asco
@dralanburguete
@tmprowell
@marklewismd
@mdandersonnews
@neerajaiims
@y_loriot
@myriadgenetics
@ginadamatomd1
@benweinbergmd

Top Replied-To in G1:
@benjaminbessemd
@y_loriot
@ibiayimd
@asco
@neerajaiims
@ginadamatomd1
@montypal
@anavmanana
@ravikanesvaran
@devikadasmd

Top Replied-To in G2:
@marklewismd
@pashtoonkasi
@benweinbergmd
@otto_dfci
@drsgraff
@drgattimays
@asco
@arunsekhri
@drhburstein
@womenofteal

Top Replied-To in G3:
@asco
@oncology_bg
@henryjoncology
@runciecwc
@weickhardtonc
@calaisjeremie
@targetingcancer
@norinansarimd
@dranitakumar
@immutep

Top Replied-To in G4:
@dralanburguete
@jacobplieth
@nooneatnowhere
@su2cscience
@takedapharma
@merusnv
@asco
@ultra_lg
@biotech2k1
@jonathanvermamd

Top Replied-To in G5:
@sabrinaycamp
@mdandersonnews
@jamecancerdoc
@funchainmd
@kznhealth
@huanglabicr
@marklewismd
@braintumordoc
@comradesrace
@benita_charles

Top Replied-To in G6:
@mdandersonnews
@teamoncology

Top Replied-To in G7:
@itneditor
@alphavestcap

Top Replied-To in G8:
@tmprowell
@hand_to_eye
@marklewismd
@jillfeldman4
@sgo_org
@megantesch
@dlueftner
@drteplinsky
@toifrogs

Top Replied-To in G9:
@jackwestmd
@mattbc

Top Replied-To in G10:
@adicetbio
@chrisdraft
@michaelwangmd

Top Mentioned
Top Mentioned in Entire Graph:
@asco
@oncoalert
@nejm
@mskcancercenter
@weoncologists
@erikahamilton9
@mdandersonnews
@danafarber
@drsgraff
@stolaney1

Top Mentioned in G1:
@asco
@oncoalert
@weoncologists
@stephenvliu
@viveksubbiah
@grecondomd
@charuaggarwalmd
@neerajaiims
@conquercancerfd

Top Mentioned in G2:
@oncoalert
@asco
@erikahamilton9
@stolaney1
@weoncologists
@drsgraff
@drgattimays
@mskcancercenter
@nejm
@faceofstage4

Top Mentioned in G3:
@asco
@pcfnews
@zklaassen_md
@walliscjd
@oncoalert
@uoft
@gacancercenter
@americancancer
@thenci
@anzuptrials

Top Mentioned in G4:
@nejm
@asco
@mskcancercenter
@andreacercek
@oncoalert
@evaluatevantage
@squawkcnbc
@claramontagut
@joanavidalb

Top Mentioned in G5:
@asco
@mdandersonnews
@nassifelise
@cleclinicmd
@pamsharmamdphd
@anaingmd
@jimallisonphd
@cshahmd
@profglongmia
@thejusjay

Top Mentioned in G6:
@camillalisanti
@weillcornell
@oncoalert
@mcristofanill
@marwamanai3
@reduzzicarol
@uber
@uber_support
@eleniandreop
@lgerratana

Top Mentioned in G7:
@oncocytecorp

Top Mentioned in G8:
@asco
@gusviani
@radiooncologia
@iaslc
@estro_rt
@medscape
@oncoalert
@chana_weinstock
@tmprowell
@fdaoncology

Top Mentioned in G9:
@asco
@fiercebiotech
@medidata
@oncoalert
@gabriellemasso9
@leilei_wuu
@in8bio
@reuters
@chandrajitraut
@silviastacchia

Top Mentioned in G10:
@biocentury
@pkluetz
@asco
@realrickpazdur
@theusonetwork
@permanentedocs
@fdaoncology
@vishalbmd
@eghorod
@janssenglobal

Top Tweeters
Top Tweeters in Entire Graph:
@uber_support
@chidambara09
@dynamocooligan
@guldeen
@gambiste1
@roblwilson
@united
@baarahk
@lizditz
@evankirstel

Top Tweeters in G1:
@roblwilson
@lehimesa
@robtropper
@raivoonet
@unitedspacecats
@le_figaro
@hughjaeger
@hopealdridge
@ruthmkb
@gailcoastie

Top Tweeters in G2:
@united
@repubblica
@netminnow
@brontyman
@washingtonpost
@profilo3marco
@pjlacasse22
@molliekatie
@ayirpelle
@abcdiagnosis

Top Tweeters in G3:
@corruptnsw
@mumaralid
@kaleidoscopet0
@telegraph
@monitor_ph
@grumpeoldman
@blkhwk0ps
@pyscalellc
@muslumkorkmaz15
@evidencerobot

Top Tweeters in G4:
@baarahk
@reuters
@gwydion620
@tates5a
@nanteos620
@jazzmanahn
@cnn
@aldu_maria
@shafeeu
@hotincleveland

Top Tweeters in G5:
@dynamocooligan
@straitarrow10
@belladonamodels
@smilenewa
@nytimes
@passarelliallan
@blueravefinn
@abc
@gladeolie
@grandma_hockey

Top Tweeters in G6:
@uber_support
@guldeen
@longlow1
@namunohi
@eimc3z
@fuku_chihuahua
@dasew01
@mongrelp
@towano_yamanako
@hassegawa

Top Tweeters in G7:
@amainsight
@matthewherper
@angelotani
@salutedomani
@richmeyer
@boobstagramm
@mloxton
@antoniocaperna
@psuvafan007
@fwpharma

Top Tweeters in G8:
@inforenique
@holliejoyjoy
@amaditalks
@pkanagaratnam
@prpeep
@centristrn
@saffiya_khan1
@randomjeweler
@doritmi
@saucedbysally

Top Tweeters in G9:
@evankirstel
@deepvard
@tighnacoille
@baronianconsult
@stupidboomers
@lindalarsonkemp
@jm_rives
@mxxntraveler
@dire_donald
@writerlyai_bot

Top Tweeters in G10:
@nick_barnes
@lwiebeld
@lllloyd1
@votanoel2024
@lisasorenson10
@bjwahlstrom
@luprice48656576
@sciam
@chicagobears
@astridvelezh


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.